Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Cancer therapy: not only cancer cells but cancer stem cells

  • In: Posters D - Formulation Design and Pharmaceutical Technology
  • At: PSWC, Melbourne (Australia) (2014)
  • Type: Poster
  • Poster code: PD-064
  • By: KIM, Jin-Seok (Sookmyung Women's university, College of Pharmacy, Seoul, South-Korea)
  • Co-author(s): Shin, Dae Hwan (Sookmyung Women's university, Seoul, South-Korea)
    Xuan, Shuahua (Sookmyung Women's university, Seoul, South-Korea)
    Lee, Seung Youn (Sookmyung Women's university, Seoul, South-Korea)
    Lee, Ji Yeon (Sookmyung Women's university, Seoul, South-Korea)
  • Abstract:

    Purpose. CD133 has recently been considered as a general CSC marker for many tumor types, especially in GBM, and GBM-CD133+ cells display glioma stem cells (GSCs) properties and appear to be highly tumorigenic. To design drug delivery systems to target the CD133+ cells, PEGylated liposomes encapsulating gemcitabine or GSISs are conjugated with..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses